Validation of the Revised Bakas Caregiving Outcomes Scale in Greek Caregivers of Patients With Advanced Cancer Receiving Palliative Radiotherapy.

Validation of the revised Bakas Caregiving Outcomes Scale in Greek caregivers of patients with advanced cancer receiving palliative radiotherapy.

Filed under: Depression Treatment

Support Care Cancer. 2012 Dec 14;
Govina O, Kotronoulas G, Mystakidou K, Giannakopoulou M, Galanos A, Patiraki E

PURPOSE: Caregiver burden considerably affects the lives of families providing care to people with advanced cancer. The aim of this study was to validate the Greek translation of the revised Bakas Caregiving Outcomes Scale (BCOS) with a sample of informal caregivers of people with advanced cancer receiving outpatient palliative radiotherapy. METHODS: Following a formal “forward-backward” method to translate the original BCOS into Greek, the scale was administered to 100 consecutive family caregivers. Participants also completed the Greek Hospital Anxiety and Depression Scale (G-HADS) and five quality-of-life related linear analogue scale assessment (LASA) scales. Validity and reliability analyses were performed. RESULTS: The Cronbach’s ? coefficient for the total BCOS score was 0.83. Test-retest reliability analysis in a subgroup of caregivers (n?=?40) revealed good short-term stability over a 2-week interval. Exploratory factor analysis generated a one-factor structure for the Greek translation, which was further confirmed through confirmatory factor analysis. Construct validity was supported through the scale’s high correlations with G-HADS anxiety (-0.524; p?HubMed – depression

 

Development of anxiety and depression in patients with benign intracranial meningiomas: a prospective long-term study.

Filed under: Depression Treatment

Support Care Cancer. 2012 Dec 14;
Goebel S, Mehdorn HM

PURPOSE: The aim of this study was to provide the first prospective longitudinal assessment of anxiety and depression in patients with a benign intracranial meningioma (WHO° I). METHODS: The Hospital Anxiety and Depression Scale was applied prior to (t1) and directly after (t2) neurosurgery as well as 6 months after surgery (t3). The research was conducted in a single treatment centre in Germany. Numerous sociodemographic, medical, psychological and cognitive accompanying measures were assessed. The study population consisted of 52 meningioma patients. Additionally, a control group of 24 patients with malignant brain tumours (astrocytoma WHO° III) was assessed. RESULTS: In meningioma patients, anxiety was high prior to surgery but declined significantly after successful neurosurgical treatment. Low levels of depression were observed at all times. In contrast, astrocytoma patients showed constantly high levels of anxiety whilst depression increased over the course of the disease. Numerous medical, psychosocial and psychological factors were associated with psychiatric morbidity in meningioma patients. CONCLUSIONS: In conclusion, psychiatric morbidity of patients with benign intracranial meningiomas was comparable to that of the general population after successful neurosurgical treatment. Numerous associated factors suggest complex relationships within a biopsychosocial model. However, due to the small sample size and recruitment in a single institution, our results are of limited generalisability and need cross-validation in future studies.
HubMed – depression

 

Dietary Intake of Magnesium May Modulate Depression.

Filed under: Depression Treatment

Biol Trace Elem Res. 2012 Dec 14;
Yary T, Aazami S, Soleimannejad K

Depressive symptoms are frequent in students and may lead to countless problems. Several hypotheses associate magnesium with depression because of the presence of this mineral in several enzymes, hormones, and neurotransmitters, which may play a key role in the pathological pathways of depression. The aim of this study was to assess whether magnesium intake could modulate depressive symptoms. A cross-sectional study was conducted on a convenience sample of 402 Iranian postgraduate students studying in Malaysia to assess the relationship between magnesium intake and depressive symptoms. The mean age of the participants was 32.54?±?6.22 years. The results of the study demonstrated an inverse relationship between magnesium intake and depressive symptoms, which persisted even after adjustments for sex, age, body mass index, monthly expenses, close friends, living on campus, smoking (current and former), education, physical activity, and marital status.
HubMed – depression

 

The Complete Depression Treatment and Homework Planner

$30.00
End Date: Tuesday Jul-23-2019 13:35:58 PDT
Buy It Now for only: $30.00
Buy It Now | Add to watch list

 

Treatment Plans and Interventions for Depression and Anxiety Disorders
$7.79
End Date: Wednesday Aug-14-2019 12:27:37 PDT
Buy It Now for only: $7.79
Buy It Now | Add to watch list

 

Depression Treatment: How to Live a Happy Life Depression Free - Depression and
$14.27
End Date: Thursday Jul-25-2019 5:13:28 PDT
Buy It Now for only: $14.27
Buy It Now | Add to watch list

 

Related Depression Treatment Information…